Skip to main content

Novel proresolving lipid mediator mimetic 3-oxa-PD1n-3 docosapentaenoic acid reduces acute and chronic itch by modulating excitatory and inhibitory synaptic transmission and astroglial secretion of lipocalin-2 in mice.

Publication ,  Journal Article
Furutani, K; Chen, O; McGinnis, A; Wang, Y; Serhan, CN; Hansen, TV; Ji, R-R
Published in: Pain
June 1, 2023

Specialized proresolving mediators (SPMs) have demonstrated potent analgesic actions in animal models of pathological pain. The actions of SPMs in acute and chronic itch are currently unknown. Recently, n-3 docosapentaenoic acid (DPA) was found to be a substrate for the biosynthesis of several novel families of SPMs and 3-oxa-PD1 n-3 DPA (3-oxa-PD1) is an oxidation-resistant metabolic stable analogue of the n-3 DPA-derived protectin D1 (PD1). In this article, we demonstrate that 3-oxa-PD1 effectively reduces both acute and chronic itch in mouse models. Intrathecal injection of 3-oxa-PD1 (100 ng) reduced acute itch induced by histamine, chloroquine, or morphine. Furthermore, intrathecal 3-oxa-PD1 effectively reduced chronic itch, induced by cutaneous T-cell lymphoma (CTCL), allergic contact dermatitis with dinitrofluorobenzene, and psoriasis by imiquimod. Intratumoral injection of 3-oxa-PD1 also suppressed CTCL-induced chronic itch. Strikingly, the antipruritic effect lasted for several weeks after 1-week intrathecal 3-oxa-PD1 treatment. Whole-cell recordings revealed significant increase in excitatory postsynaptic currents in spinal dorsal horn (SDH) neurons of CTCL mice, but this increase was blocked by 3-oxa-PD1. 3-oxa-PD1 further increased inhibitory postsynaptic currents in SDH neurons of CTCL mice. Cutaneous T-cell lymphoma increased the spinal levels of lipocalin-2 (LCN2), an itch mediator produced by astrocytes. 3-oxa-PD1 suppressed LCN2 production in CTCL mice and LCN2 secretion in astrocytes. Finally, CTCL-induced anxiety was alleviated by intrathecal 3-oxa-PD1. Our findings suggest that 3-oxa-PD1 potently inhibits acute and chronic itch through the regulation of excitatory or inhibitory synaptic transmission and astroglial LCN2 production. Therefore, stable SPM analogs such as 3-oxa-PD1 could be useful to treat pruritus associated with different skin injuries.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Pain

DOI

EISSN

1872-6623

Publication Date

June 1, 2023

Volume

164

Issue

6

Start / End Page

1340 / 1354

Location

United States

Related Subject Headings

  • Synaptic Transmission
  • Pruritus
  • Mice, Inbred C57BL
  • Mice
  • Lymphoma, T-Cell, Cutaneous
  • Lipocalin-2
  • Fatty Acids, Unsaturated
  • Astrocytes
  • Animals
  • Anesthesiology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Furutani, K., Chen, O., McGinnis, A., Wang, Y., Serhan, C. N., Hansen, T. V., & Ji, R.-R. (2023). Novel proresolving lipid mediator mimetic 3-oxa-PD1n-3 docosapentaenoic acid reduces acute and chronic itch by modulating excitatory and inhibitory synaptic transmission and astroglial secretion of lipocalin-2 in mice. Pain, 164(6), 1340–1354. https://doi.org/10.1097/j.pain.0000000000002824
Furutani, Kenta, Ouyang Chen, Aidan McGinnis, Yuqing Wang, Charles N. Serhan, Trond Vidar Hansen, and Ru-Rong Ji. “Novel proresolving lipid mediator mimetic 3-oxa-PD1n-3 docosapentaenoic acid reduces acute and chronic itch by modulating excitatory and inhibitory synaptic transmission and astroglial secretion of lipocalin-2 in mice.Pain 164, no. 6 (June 1, 2023): 1340–54. https://doi.org/10.1097/j.pain.0000000000002824.

Published In

Pain

DOI

EISSN

1872-6623

Publication Date

June 1, 2023

Volume

164

Issue

6

Start / End Page

1340 / 1354

Location

United States

Related Subject Headings

  • Synaptic Transmission
  • Pruritus
  • Mice, Inbred C57BL
  • Mice
  • Lymphoma, T-Cell, Cutaneous
  • Lipocalin-2
  • Fatty Acids, Unsaturated
  • Astrocytes
  • Animals
  • Anesthesiology